EdgarLookup

MBIA INC — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that MBIA INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
-221.3%
Profit Margin
Net income ÷ revenue
-8.8%
Return on Assets
Net income ÷ assets
-1.9x
Debt-to-Equity
Total liabilities ÷ equity
+90.5%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $80.00M Feb 26, 2026
FY2025 Dec 31, 2024 $42.00M Feb 26, 2026
FY2025 Dec 31, 2023 $7.00M Feb 26, 2026
FY2024 Dec 31, 2022 $154.00M Feb 27, 2025
FY2023 Dec 31, 2021 $189.00M Feb 28, 2024
FY2022 Dec 31, 2020 $282.00M Feb 28, 2023
FY2021 Dec 31, 2019 $280.00M Feb 28, 2022
FY2020 Dec 31, 2018 $162.00M Mar 1, 2021
FY2019 Dec 31, 2017 $433.00M Feb 27, 2020
FY2016 Dec 31, 2016 $294.00M Mar 1, 2017

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($177.00M) Feb 26, 2026
FY2025 Dec 31, 2024 $435.00M Feb 26, 2026
FY2025 Dec 31, 2023 $477.00M Feb 26, 2026
FY2024 Dec 31, 2022 ($195.00M) Feb 27, 2025
FY2023 Dec 31, 2021 ($445.00M) Feb 28, 2024
FY2022 Dec 31, 2020 ($578.00M) Feb 28, 2023
FY2021 Dec 31, 2019 ($359.00M) Feb 28, 2022
FY2020 Dec 31, 2018 ($296.00M) Mar 1, 2021
FY2019 Dec 31, 2017 ($1.61B) Feb 27, 2020
FY2016 Dec 31, 2016 ($338.00M) Mar 1, 2017

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2020 Dec 31, 2020 $97.00M Mar 1, 2021
FY2020 Dec 31, 2019 $103.00M Mar 1, 2021
FY2020 Dec 31, 2018 $91.00M Mar 1, 2021
FY2016 Dec 31, 2016 $177.00M Mar 1, 2017
FY2016 Dec 31, 2015 $190.00M Mar 1, 2017
FY2016 Dec 31, 2014 $239.00M Mar 1, 2017
FY2015 Dec 31, 2013 $384.00M Feb 29, 2016
FY2014 Dec 31, 2012 $431.00M Mar 2, 2015
FY2013 Dec 31, 2011 $371.00M Mar 3, 2014

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $38.00M Feb 26, 2026
FY2025 Dec 31, 2024 ($176.00M) Feb 26, 2026
FY2025 Dec 31, 2023 ($195.00M) Feb 26, 2026
FY2024 Dec 31, 2022 ($418.00M) Feb 27, 2025
FY2023 Dec 31, 2021 $511.00M Feb 28, 2024
FY2022 Dec 31, 2020 ($390.00M) Feb 28, 2023
FY2021 Dec 31, 2019 ($368.00M) Feb 28, 2022
FY2020 Dec 31, 2018 ($319.00M) Mar 1, 2021
FY2019 Dec 31, 2017 ($652.00M) Feb 27, 2020
FY2012 Dec 31, 2012 ($1.03B) Feb 27, 2013

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2023 Dec 31, 2023 $0 Feb 28, 2024
FY2023 Dec 31, 2022 $0 Feb 28, 2024
FY2023 Dec 31, 2021 $1.00M Feb 28, 2024
FY2022 Dec 31, 2020 $0 Feb 28, 2023
FY2021 Dec 31, 2019 $0 Feb 28, 2022
FY2020 Dec 31, 2018 $1.00M Mar 1, 2021
FY2019 Dec 31, 2017 $1.00M Feb 27, 2020
FY2016 Dec 31, 2016 $1.00M Mar 1, 2017
FY2016 Dec 31, 2015 $3.00M Mar 1, 2017
FY2016 Dec 31, 2014 $13.00M Mar 1, 2017

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.01B Feb 26, 2026
FY2025 Dec 31, 2024 $2.17B Feb 26, 2026
FY2025 Dec 31, 2023 $2.61B Feb 26, 2026
FY2024 Dec 31, 2022 $3.38B Feb 27, 2025
FY2022 Dec 31, 2021 $4.70B Feb 28, 2023
FY2021 Dec 31, 2020 $5.75B Feb 28, 2022
FY2020 Dec 31, 2019 $7.28B Mar 1, 2021
FY2019 Dec 31, 2018 $8.11B Feb 27, 2020
FY2016 Dec 31, 2016 $11.14B Mar 1, 2017
FY2016 Dec 31, 2015 $14.84B Mar 1, 2017

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $4.24B Feb 26, 2026
FY2025 Dec 31, 2024 $4.24B Feb 26, 2026
FY2024 Dec 31, 2023 $4.25B Feb 27, 2025
FY2023 Dec 31, 2022 $4.25B Feb 28, 2024
FY2022 Dec 31, 2021 $5.00B Feb 28, 2023
FY2021 Dec 31, 2020 $5.60B Feb 28, 2022
FY2020 Dec 31, 2019 $6.45B Mar 1, 2021
FY2019 Dec 31, 2018 $6.98B Feb 27, 2020
FY2016 Dec 31, 2016 $7.90B Mar 1, 2017
FY2016 Dec 31, 2015 $11.10B Mar 1, 2017

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($2.24B) Feb 26, 2026
FY2025 Dec 31, 2024 ($2.09B) Feb 26, 2026
FY2024 Dec 31, 2023 ($1.66B) Feb 27, 2025
FY2023 Dec 31, 2022 ($882.00M) Feb 28, 2024
FY2022 Dec 31, 2021 ($313.00M) Feb 28, 2023
FY2021 Dec 31, 2020 $136.00M Feb 28, 2022
FY2020 Dec 31, 2019 $826.00M Mar 1, 2021
FY2019 Dec 31, 2018 $1.12B Feb 27, 2020
FY2016 Dec 31, 2016 $3.23B Mar 1, 2017
FY2016 Dec 31, 2015 $3.73B Mar 1, 2017

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($1.77B) Feb 26, 2026
FY2025 Dec 31, 2024 ($1.59B) Feb 26, 2026
FY2024 Dec 31, 2023 ($1.14B) Feb 27, 2025
FY2023 Dec 31, 2022 ($653.00M) Feb 28, 2024
FY2022 Dec 31, 2021 ($458.00M) Feb 28, 2023
FY2021 Dec 31, 2020 ($13.00M) Feb 28, 2022
FY2020 Dec 31, 2019 $607.00M Mar 1, 2021
FY2019 Dec 31, 2018 $966.00M Feb 27, 2020
FY2016 Dec 31, 2016 $2.70B Mar 1, 2017
FY2016 Dec 31, 2015 $3.04B Mar 1, 2017

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2021 Dec 31, 2021 $160.00M Feb 28, 2022
FY2021 Dec 31, 2020 $167.00M Feb 28, 2022
FY2021 Dec 31, 2019 $83.00M Feb 28, 2022
FY2021 Dec 31, 2018 $280.00M Feb 28, 2022
FY2020 Dec 31, 2017 $146.00M Mar 1, 2021
FY2019 Dec 31, 2016 $187.00M Feb 27, 2020
FY2016 Dec 31, 2015 $522.00M Mar 1, 2017
FY2016 Dec 31, 2014 $782.00M Mar 1, 2017
FY2016 Dec 31, 2013 $1.26B Mar 1, 2017
FY2015 Dec 31, 2012 $990.00M Feb 29, 2016

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 (3) Feb 26, 2026
FY2025 Dec 31, 2024 (9) Feb 26, 2026
FY2025 Dec 31, 2023 (10) Feb 26, 2026
FY2024 Dec 31, 2022 (3) Feb 27, 2025
FY2023 Dec 31, 2021 (8) Feb 28, 2024
FY2022 Dec 31, 2020 (9) Feb 28, 2023
FY2021 Dec 31, 2019 (4) Feb 28, 2022
FY2020 Dec 31, 2018 (3) Mar 1, 2021
FY2019 Dec 31, 2017 (13) Feb 27, 2020
FY2016 Dec 31, 2016 (2) Mar 1, 2017

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 (3) Feb 26, 2026
FY2025 Dec 31, 2024 (9) Feb 26, 2026
FY2025 Dec 31, 2023 (10) Feb 26, 2026
FY2024 Dec 31, 2022 (3) Feb 27, 2025
FY2023 Dec 31, 2021 (8) Feb 28, 2024
FY2022 Dec 31, 2020 (9) Feb 28, 2023
FY2021 Dec 31, 2019 (4) Feb 28, 2022
FY2020 Dec 31, 2018 (3) Mar 1, 2021
FY2019 Dec 31, 2017 (13) Feb 27, 2020
FY2016 Dec 31, 2016 (2) Mar 1, 2017